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The Notch signaling pathway consists of several receptors
and their ligands Delta and Jagged and is important for
embryogenesis, cellular differentiation and proliferation.
Activation of Notch receptors causes their cleavage yielding
cytoplastic domains that translocate into the nucleus to
induce target proteins such as the basic-loop-helix proteins
Hes and Hey. Here we sought to clarify the significance of the
Notch signaling pathway in acute kidney injury using a rat
ischemia-reperfusion injury model and cultured NRK-52E
cells. Analysis of the whole kidney after injury showed
increased expression of Delta-1 and Hes-1 mRNA and protein
along with processed Notch-2. Confocal microscopy, using
specific antibodies, showed that Delta-1, cleaved Notch-2 and
Hes-1 colocalized in the same segments of the injured renal
proximal tubules. Recombinant Delta-1 significantly
stimulated NRK-52E cell proliferation. Our study suggests that
the Delta-1/Notch-2/Hes-1 signaling pathway may regulate
the regeneration and proliferation of renal tubules during
acute kidney injury.
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Ischemic acute kidney injury (AKI) is the most common
form of AKI in the adult population. Prominent morphologic
features of ischemic AKI include effacement and loss of
proximal tubule brush border, patchy loss of tubular cells,
focal areas of proximal tubular dilation and distal tubular
casts, and areas of cellular regeneration.1 The molecular basis
of the events leading to tubular regeneration after AKI is only
partially established. The mechanisms that lead to renal cell
proliferation and regeneration must be better understood
before novel therapeutic strategies for the treatment of
ischemic AKI can be explored. Evidence has suggested that
regeneration processes may recapitulate developmental
processes to restore organ or tissue function.2,3 Adult tubular
epithelial cells have a potent ability to regenerate after cellular
damage.4 In organisms that have suffered ischemic renal
damage, normally quiescent cells de-differentiate and acquire
the ability to proliferate through enhancements in DNA
synthesis.5,6
Regeneration processes may be similar to developmental
processes. Embryonic genes such as Wnt-4 and Ets-1 are
markedly induced in the mature kidney after ischemic renal
injury and apparently play crucial roles in the regeneration
and repair of the organ.7–9 Although initially identified in
Drosophila,10 the Notch signaling pathway is now known
to function in all metazoa as a major pathway leading to the
determination of cellular identity during developmental
stages.11,12 The expression of the pathway has been identified
in the mesonephric duct during embryonic development.
Notch is a transmembrane protein that interacts with ligands
of the Jagged and Delta families.12,13 There are four Notch
members in mammals (Notch-1–4), two Jagged-like genes,
and three Delta-like genes.14 The interaction of these ligands
with Notch activates the proteolytic cleavage of the NICD
(Notch intracellular domain).15 Transport of NICD to the
nucleus allows the domain to bind to a transcription factor,
RBP-Jk. The RBP-Jk/NICD complex activates the transcrip-
tion of a number of effectors such as Hes and Hey, two
families of basic-helix–loop–helix genes.16 Notch signaling is
reported to play a key role in nephrogenesis.17,18 Chen and
Al-Awqati19 identified the expressions of Notch-1 and -2 in
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the epithelial cells of the developing glomerulus and the
expression of Notch-2 in comma- and S-shaped bodies
(tubular components of the nephron). The same group
demonstrated the expression of Delta-1 in the tubules and in
early pretubular aggregates, and the expression of Jagged-1 in
the collecting ducts and endothelial cells of the developing
glomerulus.19 Recent experiments by Cheng et al.,20 using
conditional knockout mice demonstrated that the differen-
tiation of proximal nephron structures requires the presence
of Notch-2 but not Notch-1.
The Notch signaling pathway is also induced in mature
organs after injury. Notch-1 and Jagged-1 proteins are
upregulated in the rat liver after partial hepatectomy,21 and
NICD levels are significantly elevated in the brain after
cerebral ischemia–reperfusion.22 With regard to the renal
injury, one study reported an upregulation of Jagged-1
expression in the kidney of mice with ureteral obstruction.23
Little is known, however, about the expression and functional
roles of the Notch signaling pathway in the kidney after
ischemic injury.
In this study, we hypothesized that the Delta/Notch/Hes
pathway is activated after ischemic AKI and plays a role in the
proliferation of renal tubules. We tested this hypothesis by
examining whether the Notch signaling pathway is activated
in proximal tubules after ischemic AKI and whether the
pathway regulates the proliferation of renal tubular cells.
RESULTS
The mRNA expression of ligands (Delta-1, -4, and
Jagged-1, -2) and target proteins (Hes and Hey families)
after ischemic renal failure
To screen the renal genes for ligands (Delta-1, -3, -4, and
Jagged-1, -2) and target proteins (Hes and Hey families) in
this system, we conducted a reverse transcription-PCR (RT-
PCR) analysis of rat kidney mRNA after ischemia/reperfu-
sion. The left renal artery was clamped for 60 min and the left
kidney was excised at 0.5, 1, 2, 3, 6, 12, 24, 48, and 72 h after
reperfusion. Sham-operated kidney (0 h) and neonatal whole
body were used for control and positive control, respectively.
Delta-1, -4, and Jagged-1, -2 mRNA expressions were
screened by RT-PCR. Preliminary experiments produced no
positive band for Delta-3 at any time point in the injured
kidney, or even in the positive control (data not shown). The
mRNA level of Delta-1 was dramatically elevated from 1 to
24 h after the ischemia/reperfusion injury (Figure 1a and b).
Quantitation of ligand mRNA transcripts by real-time
quantitative PCR revealed 5.7- (1 h), 11.1- (3 h), 13.5-
(6 h), 9.2- (12 h), and 3.5-fold (24 h) increases in Delta-1
mRNA levels compared with the 0 h value (control). The
other ligands (Delta-4 and Jagged-1, -2), in contrast,
exhibited no significant changes (Figure 1a).
RT-PCR screening for the expressions of Hes-1, -5, -7,
and Hey-1, -2 mRNA revealed a significant upregulation of
the mRNA expression of Hes-1 after ischemia/reperfusion
injury in the target genes (Figure 1c). Quantitative real-time
RT-PCR assay revealed 5.4- (3 h), 6.8- (6 h), 8.0- (12 h), and
4.7-fold (24 h) increases in Hes-1 mRNA levels compared
with the 0 h value (control) (Figure 1d). The mRNA expres-
sions of the other target genes were very weak and showed no
significant changes during ischemia/reperfusion (Figure 1c).
Preliminary experiments produced no positive band for Hes-
2, -3, -4, -6, and Hey-L at any time point in the injured
kidney, or even in the positive control (data not shown). On
the basis of these data, we decided to focus on Delta-1 and
Hes-1 in our ischemia/reperfusion system in the following
experiments.
The protein expression of Delta-1, Notch-2, and Hes-1 after
ischemic renal failure
Western blot analyses were performed after ischemia/
reperfusion of the kidneys to detect the protein levels of
Delta-1 and Hes-1 (Delta-1 and Hes-1 mRNA expression
levels sharply increased), as well as those of Notch-1–4. The
Delta-1 protein expression level increased dramatically but
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Figure 1 | RT-PCR analysis of mRNA expression of ligands
(Delta-1, -4, and Jagged-1, -2) and target proteins (Hes and
Hey families) after ischemic renal failure. Bilateral renal arteries
were clamped for 60 min and kidneys were excised at 0.5, 1, 2, 3,
6, 12, 24, 48, and 72 h after reperfusion. Sham-operated rats at 0 h
served as controls. Extracted total RNAs were subjected to
quantitative PCR using the LightCycler real-time PCR for the
estimation of relative Delta-1, -4, and Jagged-1, -2 mRNA levels
and the ratio of abovementioned individual mRNAs to GAPDH
(glyceraldehyde-3-phosphate-dehydrogenase) mRNA, as
described in the Materials and Methods section. (a) The
representative agarose gels are shown. (b) The Delta-1/GAPDH
mRNA ratio is shown. Each column with a bar represents the
mean±s.e.m (n¼ 5). *Po0.05 vs control rats. (c) Extracted total
RNAs were subjected to quantitative PCR using the LightCycler
real-time PCR for the estimation of relative Hes-1, -5, -7, and
Hey-1, -2 mRNA levels and the ratio of abovementioned individual
mRNAs to GAPDH mRNA, as described in the Materials and
Methods section. The representative agarose gels are shown.
(d) The Hes-1/GAPDH mRNA ratio is shown. Each column with a
bar represents the mean±s.e.m (n¼ 5). *Po0.05 vs control rats.
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transiently, compared with the control level (sham operated,
at 0 h) 2–6 h after ischemia/reperfusion (Figure 2a). Later,
24–72 h after ischemia/reperfusion, the intensity of the
Delta-1 band gradually decreased. Quantitative analysis using
a densitometer revealed 3.5- (6 h), 6.2- (12 h), and 3.9-fold
(24 h) increases in the Delta-1 protein levels compared with
the control level (Figure 2b). The expression level of cleaved
Notch-2 (activated forms of the receptors) was significantly
elevated 2–48 h after ischemia/reperfusion. In contrast, the
expression of full-length Notch-2 decreased 2–48 h after
ischemia/reperfusion (Figure 2a). In the preliminary experi-
ments, we performed western blot analysis by using the
anti-full-length Notch-2-specific and anti-cleaved Notch-2
antibodies. However, these antibodies are not specific for
either the cleaved activated Notch-2 or full-length Notch-2,
but they recognize both forms. In the subsequent experi-
ments, we decided to use the Notch-2 antibody (Code: 100-
401-406; Rockland, Philadelphia, PA, USA), which recognizes
all forms of Notch-2. On the basis of the data obtained in the
western blot analyses, we used the Notch-2 antibody (Code:
100-401-406; Rockland) in the following studies on Notch-2.
On the one hand, quantitative analysis using a densit-
ometer revealed 2.5- (3 h), 4.7- (6 h), and 4.2-fold (12 h)
increases in the cleaved Notch-2 protein level compared with
the control level. On the other hand, 0.55- (3 h), 0.35- (6 h),
and 0.47-fold (12 h) decreases were observed in the full-
length Notch-2 protein level compared with the control level
(Figure 2b). The expression levels of both forms of Notch-2
returned to the basal level 72 h after ischemia/reperfusion.
The expression of Hes-1 was weak in the control kidney and
increased dramatically but transiently 6–24 h after ischemia/
reperfusion. Later, 72 h after ischemia/reperfusion, this
upregulation of Hes-1 was no longer observed (Figure 2a).
Quantitative densitometric analysis revealed 3.7- (6 h), 3.8-
(12 h), and 3.2-fold (24 h) increases in the Hes-1 protein level
compared with the control level (Figure 2b). No increases
were detected in the expression levels of cleaved Notch-1,
cleaved Notch-3, full-length Notch-3 (data not shown),
cleaved Notch-4, or full-length Notch-4 (data not shown)
under our experimental conditions. Immunoblotting was
performed, with actin as a loading marker (Figure 2a). The
protein levels of Delta-1, Hes-1, and cleaved Notch-2
remained unchanged 6–12 h after the sham operation in the
control animals (data not shown).
Immunohistochemical examination of Delta-1 in ischemic
renal injury
We next performed immunohistological studies on Delta-1
using confocal microscopy. A low-power view revealed Delta-1
expression in the outer medulla and cortical renal tubules
at 12 h after ischemia/reperfusion, but not in the inner
medulla. When the anti-aquaporin-1 antibody was used as
a marker of the proximal tubules, the Delta-1 expression
was found to be colocalized with aquaporin-1 in the outer
medulla and cortex after ischemia/reperfusion (Figure 3a and
b). In the control kidneys, aquaporin-1 expression was clearly
observed in the renal cortex and medulla, but Delta-1
expression was not observed (Figure 3a and b). Only minimal
staining of aquaporin-1 was observed in the inner medulla of
the ischemic/reperfusion and control kidneys. A high-power
view of samples stained with antibodies for both Delta-1 and
aquaporin-1 revealed positive staining for both these proteins
in the same proximal tubular cells in the outer medulla.
Furthermore, Delta-1 was expressed in the cytoplasm of
tubular cells (Figure 4). These results demonstrated the
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Figure 2 | Western blot analyses of protein expression after
ischemic renal failure. (a) Extracted protein (50 mg) from renal
tissue was separated by SDS-PAGE (sodium dodecyl sulfate-
polyacrylamide gel electrophoresis) gels. Delta-1, Notch-2, Hes-1,
cleaved Notch-1, cleaved Notch-3, and cleaved Notch-4 protein
levels were detected by western blot analysis. In the preliminary
experiments, we performed western blot analysis by using the
anti-full-length Notch-2-specific and anti-cleaved Notch-2
antibodies. However, these antibodies are not specific for either
the cleaved activated Notch-2 or full-length Notch-2, but they
recognize both forms. In the subsequent experiments, we decided
to use the Notch-2 antibody (Code: 100-401-406; Rockland), which
recognizes all forms of Notch-2. Western blots of actin as loading
controls are shown. (b) Quantitative analyses using a
densitometer were performed for Delta-1, full-length Notch-2,
cleaved Notch-2, and Hes-1. Each bar represents the mean±s.e.m
(n¼ 6). *Po0.05 vs control (0 h) by the ANOVA test. C, control;
M, molecular weight marker.
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prevalence of Delta-1 expression in the proximal tubules,
mainly the S3 segment, of the renal cortex at 12 h after
ischemia/reperfusion.
Immunohistochemical examination of Notch-2 in ischemic
renal injury
Immunohistochemical studies on Notch-2 performed by
using confocal microscopy revealed a clear expression
of Notch-2 in the outer medulla and cortical renal tubules
at 12 h after ischemia/reperfusion, but no expression was
observed in the inner medulla. Positive, although weak,
Notch-2 expression was observed in the renal cortices of the
control. The expression of Notch-2 was found to be
colocalized with that of aquaporin-1 in the outer medulla
and cortex after ischemia/reperfusion (Figure 5a and b). On
the basis of the data obtained in the western blot analyses, we
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Figure 3 | Immunohistochemical examination of Delta-1 after
ischemic renal failure. (a) Immunohistochemical analyses of the
renal cortex were performed at a low-power view (original
magnification,  100) by using antibodies against Delta-1 and
aquaporin-1 (AQP-1) and in a merged condition at 12 h after
ischemic injury (upper panels). The corresponding analyses
carried out in control kidneys are shown in the lower panels.
(b) Immunohistochemical analyses of the renal medulla
performed at a low-power view (original magnification,  100)
with antibodies against Delta-1 and aquaporin-1 and in a merged
condition at 12 h after ischemic injury were carried out in AKI
kidneys (upper panels) and in control kidneys (lower panels).
IM, inner medulla; Merge, merged condition; OM, outer medulla.
Delta-1 AQP-1 DAPI Merge
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AKI
Control
Figure 4 | Immunohistochemical examination (high-power
views) of Delta-1 in the renal outer medulla of ischemic/
reperfused kidneys. Immunohistochemical analyses of the renal
outer medulla performed at a high-power view (original
magnification,  600) by using antibodies against Delta-1,
aquaporin-1 (AQP-1), and 40,6-diamidino-2-phenylindole (DAPI)
and in a merged condition at 12 h after ischemic injury were
carried out in AKI kidneys (upper panels) and in control kidneys
(lower panels).
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Figure 5 | Immunohistochemical examination of cleaved
Notch-2 in the renal cortex of ischemic/reperfused kidneys.
(a) Immunohistochemical analyses of the renal cortex were
performed at a low-power view (original magnification,  100) by
using antibodies against Notch-2 and aquaporin-1 (AQP-1) and in
a merged condition at 12 h after ischemic injury (upper panels).
The corresponding analyses carried out in control kidneys are
shown in the lower panels. (b) Immunohistochemical analyses of
the renal cortex performed at a low-power view (original
magnification,  100) using antibodies against Notch-2 and
AQP-1 and in a merged condition at 12 h after ischemic injury
were carried out in AKI kidneys (upper panels) and in control
kidneys (lower panels). IM, inner medulla; Merge, merged
condition; OM, outer medulla.
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used the Notch-2 antibody (Code: 100-401-406; Rockland) in
the immunohistochemical studies on Notch-2. A high-power
view of samples stained with antibodies for both Notch-2 and
aquaporin-1 revealed positive staining in the same proximal
tubular cells in the outer medulla. Notch-2 was detectable in
the cytoplasm and the nuclei in the ischemic/reperfused
kidney and the membrane of the control kidney (Figure 6a).
Next, a double-staining examination of Notch-2 and
Delta-1 confirmed the colocalization of Notch-2 and Delta-1
in the same renal tubules (Figure 6b). These results
demonstrate the prevalence of the expression of Notch-2 in
the segments (mainly the S3 segment) of the renal tubules
positive for Delta-1 expression at 12 h after ischemia/
reperfusion.
Immunohistochemical examination of Hes-1 in ischemic renal
injury
The immunohistological studies on Hes-1 were performed
using confocal microscopy. Hes-1 expression was observed in
the cortical and outer medullary renal tubules at 12 h after
ischemia/reperfusion, but not in the inner medullary renal
tubules. It was also not observed in the renal cortices of
the control rats. The expression of Hes-1 was found to be
colocalized with that of aquaporin-1 in the outer medulla
and cortex after ischemia/reperfusion (Figure 7a and b). A
high-power view of the samples stained with antibodies for
both Hes-1 and aquaporin-1 revealed positive staining in the
nuclei of the same proximal tubular cells in the outer medulla
(Figure 8a). Next, we performed a double-staining examina-
tion of Hes-1 and Delta-1. As shown in Figure 8b, the
expression of Hes-1 was colocalized in the same renal tubules
with that of Delta-1. These results demonstrate the
prevalence of Hes-1 expression in the same segment (mainly
the S3 segment) of the renal cortex positive for Delta-1
expression at 12 h after ischemia/reperfusion and the
presence of Hes-1 staining in proximal tubular cells.
Notch-2 AQP-1 DAPI Merge
Notch-2 Delta-1 DAPI Merge
AKI
Control
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Control
(×600)
(×600)
Figure 6 | Immunohistochemical examination (high-power
views) of Notch-2 in the renal outer medulla of ischemic/
reperfused kidneys. (a) Immunohistochemical analyses of the
renal outer medulla were performed at a high-power view
(original magnification,  600) by using antibodies against
Notch-2 aquaporin-1 (AQP-1), and 40,6-diamidino-2-phenylindole
(DAPI) and in a merged condition at 12 h after ischemic injury
(upper panels). The corresponding analyses carried out in control
kidneys are shown in the lower panels. (b) Immunohistochemical
analyses of the renal outer medulla performed at a high-power
view (original magnification,  600) by using antibodies against
Notch-2, Delta-1, and DAPI and in a merged condition at 12 h after
ischemic injury were carried out in AKI kidneys (upper panels) and
in control kidneys (lower panels).
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Figure 7 | Immunohistochemical examination of Hes-1
in the renal cortex of ischemic/reperfused kidneys.
(a) Immunohistochemical analyses of the renal cortex were
performed at a low-power view (original magnification,  100) by
using antibodies against Hes-1 and aquaporin-1 (AQP-1) and in
a merged condition at 12 h after ischemic injury (upper panels).
The corresponding analyses carried out in control kidneys are
shown in the lower panels. (b) Immunohistochemical analyses
of the renal medulla performed at a low-power view (original
magnification,  100) by using antibodies against Hes-1 and
AQP-1 and in a merged condition at 12 h after ischemic injury
were carried out in AKI kidneys (upper panels) and in control
kidneys (lower panels). IM, inner medulla; Merge, merged
condition; OM, outer medulla.
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Antibody specificity for Delta-1, Notch-2, and Hes-1
in immunohistological and western blot analyses
We performed immunohistological analysis by using
blocking peptides to verify the specificity of the Delta-1,
Notch-2, and Hes-1 antibodies. As shown in Figure 9a–c, the
immunohistological signals for Delta-1, Notch-2, and Hes-1
diminished significantly in the presence of the blocking
peptide for each antibody. Further, we performed western
blot analyses by using blocking peptides to confirm the
specificity of the Delta-1, Notch-2, and Hes-1 antibodies.
As shown in Figure 9d–f, the bands obtained for Delta-1,
Notch-2, and Hes-1 at 6 h after ischemia/reperfusion
diminished significantly in the presence of the blocking
peptide for each antibody. These results confirmed the
antibody specificity.
Delta-1 stimulated cellular proliferation and Hes-1
expression in NRK-52E cells
Next, we used a culture system with NRK-52E cells to
examine the functional role of the Delta-1 system in renal
tubular cells. To examine whether this culture system mimics
the in vivo ischemia/reperfusion model, we investigated the
expressions of Delta-1 and Hes-1 mRNA by RT-PCR and the
expressions of Delta-1, cleaved Notch-2, and Hes-1 protein
by western blot analysis. Hypoxia (12 h) upregulated the
mRNA expressions of Delta-1 and Hes-1 by 1.8- and 4.5-fold,
respectively, compared with the levels in control NRK-52E
cells (Figure 10a and b). In the western blot analysis, hypoxia
Hes-1 AQP-1 DAPI Merge
Hes-1 Delta-1 DAPI Merge
(×600)
(×600)
AKI
Control
AKI
Control
Figure 8 | Immunohistochemical examination (high-power
views) of Hes-1 in the renal outer medulla of ischemic/
reperfused kidneys. (a) Immunohistochemical analyses of the
renal outer medulla were performed at a high-power view
(original magnification,  600) by using antibodies against Hes-1
and aquaporin-1 (AQP-1) and 40,6-diamidino-2-phenylindole
(DAPI) and in a merged condition at 12 h after ischemic injury
(upper panels). The corresponding analyses carried out in control
kidneys are shown in the lower panels. (b) Immunohistochemical
analyses of the renal outer medulla performed at a high-power
view (original magnification,  600) by using antibodies against
Hes-1, Delta-1, and DAPI and in a merged condition at 12 h after
ischemic injury were carried out in AKI kidneys (upper panels) and
in control kidneys (lower panels).
Blocking peptide
Blocking peptide
Blocking peptide
Blocking peptide
– +
– +
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– +
Delta-1
Notch-2
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Delta-1
Notch-2
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Actin
Actin
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Figure 9 | Immunohistochemical investigations and western
blot analyses of the specificity of antibodies for Delta-1,
Notch-2, and Hes-1. (a) Immunohistochemical analyses of
the renal cortex were performed under a high-power view
(original magnification,  600) by using antibodies against
Delta-1 at 12 h after ischemic injury (left panel) and in the
presence of the blocking peptide for Delta-1 (right panel).
(b) Immunohistochemical analyses of the renal cortex were
performed under a high-power view (original magnification,
 600) by using antibodies against Notch-2 at 12 h after ischemic
injury (left panel) and in the presence of the blocking peptide for
Notch-2 (right panel). (c) Immunohistochemical analyses of the
renal cortex were performed under a high-power view (original
magnification,  600) by using antibodies against Hes-1 at
12 h after ischemic injury (left panel) and in the presence of
the blocking peptide for Hes-1 (right panel). (d–f) Protein
(50mg) extracted from the renal tissue at 6 h after ischemia/
reperfusion was resolved over SDS-PAGE (sodium dodecyl
sulfate-polyacrylamide gel electrophoresis) gels. Western blot
analyses were performed in the absence or presence of the
blocking peptide. The Delta-1 (d), Notch-2 (e), and Hes-1
(f) protein levels were detected by performing western blot
analyses in the absence (left lanes) and presence of blocking
peptides (right lanes). The western blots obtained for actin
that was used as the loading control are also shown.
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(12 h) upregulated the protein expressions of Delta-1, cleaved
Notch-2, and Hes-1 by 2.5-, 2.3-, and 4.1-fold, respectively,
compared with the control levels (Figure 10c and d).
Next, to clarify the function of Delta-1 pathway in renal
tubule cells, recombinant Delta-1 was used to stimulate
NRK-52E cells as described previously.24 Recombinant Delta-
1 was plated onto the cell culture plates and NRK-52E cells
were cultured in the wells. The cell morphologies were obser-
ved and cell counts were taken for 5 days. The NRK-52E cell
count in the presence of Delta-1 was significantly increased,
compared with the control level (Figure 10a and b). Figure
11a shows a typical morphology of an NRK-52E cell in this
experiment. The morphology changed only slightly, whereas
the cell count increased significantly. We also examined
the effects of Delta-1 on the cell proliferation of NRK-52E
cells by [3H]thymidine uptake. Recombinant Delta-1 stimu-
lated [3H]thymidine uptake to 205% dose-dependently
(Figure 11b and c). Taken in sum, these results demonstrate
a Delta-1-induced increase in the proliferation of NRK-52E
cells. To explore further, we also examined the signal
transduction of recombinant Delta-1 in NRK-52E cells.
Delta-1 upregulated the mRNA expression of Hes-1 by 2.2-
fold, compared with the control level in NRK-52E cells
(Figure 12a and b). In western blot analysis, Delta-1 upregu-
lated the protein expressions of cleaved Notch-2 and Hes-1
by 3.2- and 4.5-fold, respectively, compared with the controls
(Figure 12c and d). Taken together, the results of these
experiments confirmed that Delta-1 stimulation upregulated
Hes-1 and cleaved Notch-2 in NRK-52E cells. Thus, we have
established that Delta-1 stimulates Notch-2/Hes-1 pathway
in renal tubular cell.
DISCUSSION
In this study, we demonstrate that the Delta-1/Notch-2/Hes-1
pathway is strongly upregulated in the proximal tubules of
rat kidney after ischemic AKI. Our findings also demonstrate
that the Notch system induces the proliferation of renal
tubular cells.
The recovery from AKI requires the replacement of
damaged cells with new ones to restore the integrity of the
tubular epithelium. The regeneration processes are charac-
terized by proliferation of dedifferentiated cells followed by
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Figure 10 | RT-PCR analysis of the expressions of Delta-1
and Hes-1 mRNA and the protein expressions of Delta-1,
Cleaved Notch-2, and Hes-1 of NRK-52E cells under a hypoxic
condition. (a) Extracted RNA (1 mg) from NRK-52E cells was used
for quantitative RT-PCR analyses for Delta-1, Hes-1, and GAPDH
(glyceraldehyde-3-phosphate-dehydrogenase) mRNA levels.
Typical agarose gels are shown. (b) Quantitative analyses were
performed for Delta-1 and Hes-1 mRNAs. Each bar represents
the mean±s.e.m (n¼ 6). *Po0.05 vs control by the ANOVA test.
(c). Extracted protein (50 mg) from NRK-52E cells was separated
by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel
electrophoresis) gels. Delta-1, cleaved Notch-2, and Hes-1 protein
levels were detected by western blot analysis. Western blots of
actin as loading controls are shown. (d) Quantitative analyses
using a densitometer were performed for Delta-1, cleaved
Notch-2, and Hes-1. Each bar represents the mean±s.e.m
(n¼ 6). *Po0.05 vs control by the ANOVA test.
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Figure 11 | Delta-1-stimulated cell numbers of renal tubular
cells (NRK-52E). Recombinant Delta-1 was plated onto each well
of a 96-well culture plate. NRK-52E cells were cultured for 5 days.
The morphologies and cell counts were observed for 5 days.
(a) Typical morphology of NRK-52E cell in controls (left panel) and
in a Delta-1-stimulated condition (right panel). (b) The NRK-52E
cell count in the presence of Delta-1 was significantly higher than
the control level. (c) We examined the effects of recombinant
Delta-1 on the cell proliferation of NRK-52E cells by [3H]thymidine
uptake. Each bar represents the mean±s.e.m (n¼ 6). *Po0.05 vs
control by the ANOVA test.
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differentiation of daughter cells into the required cell pheno-
type.3–5 Noting that a similar phenomenon occurs during
embryogenesis, our group and some others have postulated
that these regeneration processes may redeploy certain parts
of the genetic program executed during organogenesis to
reestablish proper tissue function in the kidney.3,5,7,8 A
previous study by our group revealed the expression of the
developmental gene Wnt-4 in ischemic AKI and confirmed
that this gene promotes the proliferation of renal tubular
cells.7 We also reported that Ets-1 is upregulated in the
proximal tubules in the recovery phase of AKI and highly
expressed in the embryonic kidney.8 These previous papers
suggest that certain developmental genes are reexpressed
during the recovery from AKI and play key roles in tubular
regeneration. To confirm this hypothesis, we examined the
expression patterns and functions of the Delta/Notch/Hes
pathway in an AKI model and renal tubular cells.
This study is the first to demonstrate the upregulation of
Delta-1 expression in the early phase of ischemic AKI. The
Delta-1 expression was localized exclusively in the proximal
tubule. The Notch system includes many kinds of ligands
(Delta-1, -3, -4, Jagged-1, and -2) and target genes (Hes-1,
Hes-2, Hes-3, Hes-4, Hes-5, Hes-6, Hes-7, Hey-1, Hey-2, and
Hey-L). For our study, we were required to perform a
RT-PCR analysis of these ligands and target gene mRNAs
for screening purposes (Figure 1). We detected strong bands
for Delta-1 and Hes-1 after ischemia/reperfusion, but
no bands were detected for Delta-3, -4, Jagged-1, -2, Hes-2,
-3, -4, -5, -6, -7, Hey-1, -2, or -L under our experimental
conditions. The protein expressions of Delta-1 and Hes-1
also increased dramatically during the ischemia/reperfusion.
Next, western blot analyses for Notch-1–4 proteins revealed a
significant increase in the expression level of cleaved Notch-2
and decrease in that of full-length Notch-2 during ischemia/
reperfusion; however, no significant change was observed in
the cleaved Notch-1, cleaved Notch-3, or cleaved Notch-4. It
was shown that the reduction in the level of full-length
Notch-2 was associated with an increase in that of cleaved
Notch-2. Chen and Al-Awqati19 identified the expressions of
Delta-1 and Notch-2 in the prospective proximal tubules of
embryonic kidney. Further, Chang et al.20 found that the
distal tubules developed in Notch-2-deficient kidneys lacked
proximal tubules and podocytes, whereas those developed in
Notch-1-deficient kidneys were normal. Our results agree
with those of other recent studies on the importance of
Notch-2 in the regeneration of the proximal tubule. The
detection of Delta-1 and cleaved Notch-2 upregulation in
proximal tubules after AKI suggests that these proximal
tubules are at least partially embryonic in character. Our
present study is also the first to demonstrate the significant
induction of the effector protein Hes-1 in the proximal
tubule after AKI. The expressions of Hes-1, -5, Hey-1, and -L
have been identified in the developing nephron, but they have
not been analyzed to screen for Hes-1 in AKI.17–20 The
functional difference between the Hes and Hey families
has not been clarified.25,26 Our experiments detected no clear
induction of Hes-5, -7, Hey-1, or -2, as shown in Figure 1.
Further studies are necessary to gain a more precise
understanding of the expressions of the Delta/Notch/Hes
pathway after ischemia/reperfusion injury.
In the next round of experiments for our study, we
examined the immunohistology of Delta-1, Notch-2, and
Hes-1 under a confocal microscope. Delta-1 expression was
mainly observed in the S3 segment of the proximal tubules
at 12 h after ischemia/reperfusion, and the expressions of
Notch-2 and Hes-1 were apparently colocalized with that of
Delta-1 in the proximal tubules of the renal cortex and outer
medulla at the same time point (Figures 3–8). In addition,
immunohistochemical investigations and western blot
analyses performed using blocking peptides confirmed the
antibody specificity for Delta-1, Notch-2, and Hes-1. The
proximal tubular cells have been established to be highly
sensitive to ischemic injury and regenerate in the nephron
segments.27,28 Our immunohistological studies clearly iden-
tified the expressions of Delta-1, cleaved Notch-2, and Hes-1
in the same segments after ischemia/reperfusion. Our in vivo
Cont Delta-1
Cont Delta-1
Hes-1
GAPDH
Cleaved
Notch-2
Hes-1
H
es
-1
 p
ro
te
in
Actin
Control Delta-1
Control Delta-1
H
es
-1
 m
R
N
A 
ra
tio
(%
 of
 co
ntr
ol)
3
2
1
0
Control Delta-1
∗
∗
∗
Cl
ea
ve
d 
No
tc
h-
2
pr
ot
ei
n 
ex
pr
es
sio
n
e
xp
re
ss
io
n
4
3
2
1
0
4
5
6
3
2
1
0
Figure 12 | RT-PCR analysis of Hes-1 mRNA and protein
expressions of cleaved Notch-2 and Hes-1 in the presence of
Delta-1 of NRK-52E cells. (a) Extracted RNA (1 mg) from NRK-52E
cells was used for quantitative RT-PCR analyses for Hes-1 and
GAPDH (glyceraldehyde-3-phosphate-dehydrogenase) mRNA
levels in the presence of Delta-1 and in a control condition.
Typical agarose gels are shown. (b) Quantitative analyses using a
densitometer were performed for Hes-1 mRNAs in the presence of
Delta-1 and Cont. Each bar represents the mean±s.e.m (n¼ 6).
*Po0.05 vs control by the ANOVA test. (c). Extracted protein
(50mg) from NRK-52E cells was separated by SDS-PAGE (sodium
dodecyl sulfate-polyacrylamide gel electrophoresis) gels. Cleaved
Notch-2 and Hes-1 protein levels were detected by western blot
analysis in the presence of Delta-1 and Cont. Western blots of
actin as loading controls are shown. (d) Quantitative analyses
using a densitometer were performed for cleaved Notch-2 and
Hes-1. Each bar represents the mean±s.e.m (n¼ 6). *Po0.05 vs
control by the ANOVA test.
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results, meanwhile, strongly suggested that this pathway is
capable of regulating the proliferation and regeneration
of proximal tubular cells. The Notch pathway reportedly
plays a key role in the regeneration of the liver and brain
after injury.21,22 Nonetheless, our in vivo study did not clarify
the functional role of the Delta-1/Notch-2/Hes-1 pathway
in cellular proliferation in renal tubular cells. Our next
step, therefore, was to prepare a cell culture system using
recombinant Delta-1.
The purposes for preparing the cell culture were to
examine the functional role of Delta-1 signaling in renal
tubular cells (NRK-52E cells). In some instances, it may be
inappropriate to extend the in vitro results to in vivo condi-
tions. First, we performed an RT-PCR and western blot
analysis of NRK-52E cells under hypoxic conditions to
determine whether hypoxic stress activates Delta-1, Notch-2,
and Hes-1. We found that the mRNA and protein expressions
of Delta-1, cleaved Notch-2, and Hes-1 were upregulated in
NRK-52E cells under hypoxic conditions (Figure 9). This is
the first known evidence of hypoxia-induced upregulation of
Delta-1 and Hes-1 in renal cells. These data suggest that the
findings of the NRK-52E cells under hypoxic conditions were
similar to those of the abovementioned in vivo studies on the
induction of the Delta-1/Notch-2/Hes-1 pathway. Next, to
clarify the function of the Delta-1 pathway, recombinant
Delta-1 was used to stimulate NRK-52E cells. This is the first
study to demonstrate Delta-1-induced increases in the cell
counts and proliferation of renal tubular cells. In the final
experiment, the interactions between Delta-1 and Notch-2
and that between Delta-1 and Hes-1 were clarified when we
observed that Delta-1 stimulation increased the expressions
of cleaved Notch-2 and Hes-1 proteins in NRK-52E cells. Our
in vitro data suggest that the Delta-1/Notch-2/Hes-1 pathway
has an important role in the regeneration of renal tubular
cells in AKI. Other data, meanwhile, revealed that the Delta/
Notch/Hes pathway also plays multiple roles in cell migration
and cell identification during development.11,18,29 The use
of other experimental approaches in the future will help
broaden the understanding of the functional roles of the
Delta/Notch/Hes pathway in AKI.
In summary, our study has produced two novel findings:
first, the Delta-1/Notch-2/Hes-1 pathway is activated after
ischemic AKI; second, Delta-1 has an important role in the
proliferation of renal tubules. The Delta-1/Notch-2/Hes-1
pathway may regulate the regeneration and proliferation of
renal tubules in AKI. Further studies are necessary to gain a
more precise understanding of the molecular mechanisms of
renal recovery after ischemia/reperfusion injury.
MATERIALS AND METHODS
Induction of ARF
Male Sprague–Dawley rats (Saitama Experimental Animal Supply,
Saitama, Japan) weighing 150–200 g were anesthetized intraperito-
neally with sodium pentobarbital (30 mg kg1) at surgery. The left
renal artery was occluded with Sugita aneurysm clips (Mizuho
Ikakogyo, Tokyo, Japan) for 60 min. The clamps were removed, the
incisions were closed, and the rats were killed at 0.5, 1, 2, 3, 6, 12, 24,
48, and 72 h (n¼ 5). The left kidney was quickly removed and
processed for histological evaluation, protein extraction, or RNA
extraction.7,8 Age- and weight-matched Sprague–Dawley rats
received sham operations without clamping of the renal arteries at
0, 6, 12, and 24 h (n¼ 3).
Cell and cell culture and exposure to hypoxia
NRK-52E cells (renal tubular cells of adult rat kidney) originally
purchased from American Type Culture Collection (Rockville, MD,
USA) were grown in Dulbecco’s modified Eagle’s medium (Gibco,
Tokyo, Japan) supplemented with 50 IU ml1 penicillin and 10%
heat-inactivated fetal calf serum (Gibco). Once grown, the cells were
cultured at 37 1C in either 20% O2 and 5% CO2 (the normoxic
condition) or in a hypoxic chamber (Bellow Glass Inc., Vineland, NJ,
USA) containing 0% O2 and 5% CO2 (the hypoxic condition).
8
Isolation of kidney tissue and histological examination
The rats were anesthetized with pentobarbital at indicated
times after the ischemic event. Their kidneys were perfused with
sterile phosphate-buffered saline (PBS). The left kidney was quickly
excised. For immunohistochemical studies, the kidney was removed
after in vitro perfusion with 4% paraformaldehyde in a phosphate
buffer and immersed overnight in the same fixative at 4 1C. The
fixed tissue was cryoprotected by immersion in 20% sucrose in PBS
at 4 1C and then shock-frozen in liquid nitrogen. Frozen 7 mm
sections were cut with a cryostat, thaw-settled on slides, mounted
with an aqueous mounting medium (Mount-Quick Aqueous;
Daido Sangyo, Tokyo, Japan), and examined under a confocal
laser microscope (Carl Zeiss Japan, Tokyo, Japan). Frozen sections
prepared in the manner described above were used for immuno-
histochemistry.7 Immunohistochemical staining was performed
using an anti-Delta-1-specific antibody (ab10554; Abcam Inc.,
Cambridge, MA, USA), anti-Notch-2-specific antibody (no. 11172;
Rockland), anti-Hes-1-specific antibody (AB5702; Chemicon Inter-
national Inc., Dundee, UK), and anti-aquaporin-1-specific antibody
(ab9566; Abcam Inc.) as markers for proximal tubules, as described
previously.30,31 The secondary antibodies were an anti-goat IgG
FITC-conjugated antibody, an anti-rabbit IgG Cy3-conjugated
antibody, an anti-rabbit IgG FITC-conjugated antibody, an anti-
sheep IgG Cy3-conjugated antibody, and an anti-goat IgG Cy3-
conjugated antibody (Sigma, St Louis, MO, USA). The sequences of
the blocking peptides used were as follows: Delta-1, CGEEWSQDL
HSSGRTDLRYS; Notch-2, CRDASNHKRREPVGQD; and Hes-1,
TPDKPKTASEH. The blocking peptide (10 mg ml1) was preloaded
onto the histology sections or immunoblot membranes before the
addition of the antibody.
Western blot analysis
A 50 mg portion of protein samples (total renal tissue or NRK-52E
cells), prepared as described above, were denaturated at 100 1C for
5 min in an sodium dodecyl sulfate sample buffer and separated on
7.5 or 10/20% polyacrylamide electrophoresis gel.32 The proteins
were transferred to a nitrocellulose membrane, blocked for 1 h with
5% (w/v) fat-free milk powder, and probed with the primary
antibody. Western blot analysis was performed using an anti-Delta-
1-specific antibody, anti-Notch-2-specific antibody, anti-Hes-1-
specific antibody, anti-cleaved Notch-1-specific antibody
(Val-1744; Cell Signaling Technology Inc., Beverly, MA, USA),
anti-Notch-3-specific antibody (M-20, sc-7424; Santa Cruz
Biotechnology Inc., Santa Cruz, CA), anti-Notch-4-specific antibody
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(M-19, sc-8646; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA), and anti-actin-specific antibody (H-300, sc-10731; Santa
Cruz Biotechnology Inc.). The primary antibodies were detected
using horseradish peroxidase-conjugated rabbit anti-goat IgG and
donkey anti-rabbit IgG, and visualized by the Amersham ECL
system (Amersham Corp., Arlington Heights, IL, USA). In the
preliminary experiments, we performed western blot analysis by
using the anti-full-length Notch-2-specific and anti-cleaved Notch-2
antibodies. However, these antibodies are not specific for either the
cleaved activated Notch-2 or full-length Notch-2, but they recognize
both forms. In the subsequent experiments, we decided to use the
Notch-2 antibody (Code: 100-401-406; Rockland), which recognizes
all forms of Notch-2. On the basis of the data obtained in the
western blot analyses, we used the Notch-2 antibody (Code: 100-401-
406; Rockland) in the immunohistochemical studies on Notch-2.
Real-time quantitative PCR
A RT-PCR analysis with RNA extracted from the ischemia/
reperfusion kidneys was carried out as described previously.33 The
primers used are described in Table 1. Total RNA was harvested from
renal tissue using TRI-REAGENT (Life Technologies, Gaithersburg,
MD, USA).33 A 1 mg portion of total RNA samples was used for the
RT-PCR, as follows. The real-time quantitative PCR method was
used to accurately detect the changes in Delta-1 and Hes-1 gene
copies. The RT-PCR of GAPDH (glyceraldehyde-3-phosphate-
dehydrogenase) served as a positive control. A three-step PCR was
performed for 35 cycles. The samples were denatured at 94 1C for
30 s, annealed at 58 1C for 30 s, and extended at 72 1C for 30 s. The
PCR products were subcloned to the TA cloning vector (Promega
Biotec, Madison, WI, USA) as described previously.33 The plasmids
containing ligand cDNA and GAPDH cDNA were used to make
standard curves of quantitative PCR.34 The linear curves between
the PCR products and cDNA quantities (10 pg ml1 to 100 ng ml1)
with the use of Delta-1, Hes-1, and GAPDH cDNA plasmids were
observed in the ranges used.
Effects of Delta-1 on the cell count and cell proliferation
The effect of Delta-1 on cell growth was examined as described
previously.35 The recombinant Notch ligand protein Delta-1 was
synthesized as described previously.24 Briefly, partial cDNAs
encoding the extracellular domain of Delta-1 was fused in-frame
to a sequence of IgG-Fc. The gene fusion was inserted into an
expression vector and electroporated into Chinese hamster ovary
cells. The chimeric protein was purified from conditioned media by
affinity chromatography. Delta-1 was immobilized in the wells of a
96-well culture plate (Becton-Dickinson Labware, Franklin Lakes,
NJ, USA) and in the wells of a 10 cm culture plate by loading the
wells with Delta-1 dissolved at a concentration of 5.0 mg ml1 in PBS
at 37 1C for 2 h. The amount used had been confirmed to exert
the maximum effect in preliminary experiments. PBS alone was
placed in the wells under similar conditions as a control for Delta-1.
The wells were then blocked with PBS containing 5% bovine
serum albumin and washed with PBS. The cells (104 cells per well)
were cultured in 0.1 ml of Dulbecco’s modified Eagle’s medium. The
cells in the 96-well culture plate were counted by microscopy or
protein, and the mRNA from the 10 cm culture plate was harvested
for 1–5 days. The cells were plated in 24-well plates and incubated
in a medium with recombinant Delta-1 at indicated concentrations
for 3 days. For the last 12 h, the cells were pulsed with 1 mCi
[3H]thymidine (Amersham Corp.). After the incubation, the cells
were redissolved in 0.5 M NaOH, and counted in an Aquasol-2
scintillation cocktail (NEN Research Products, Boston, MA, USA).8
Statistics
The results are presented as means±s.e.m. The differences were
tested using a two-way analysis of variance followed by Scheffe’s test
for multiple comparisons. Two groups were compared by the
unpaired t-test. Po0.05 was considered significant.
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